 As a stellar drug for hereditary angioedema, BioCryst Pharmaceuticals Orladeyo is enjoying strong sales reactions in its second year of launch. Coupled with ongoing global market expansions and on top of its efficacy, Orledayo is poised to become a blockbuster in the next few years. 